Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DNA-intercalating agents reported by Mitsui Toatsu in patent literature

Nov. 25, 1997

Daiichi synthesizes paclitaxel derivatives

Nov. 25, 1997

Axiom, Zaiya and Nippon Kagaku anticancer drug discovery alliance

Nov. 25, 1997

Techniclone reacquires rights to Oncolym

Nov. 25, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

Imutec licenses novel anticancer compounds from Ion

Nov. 21, 1997

New antitumor compound QM16-A described in patent literature

Nov. 21, 1997

HMR and MediGene collaborate on cancer gene therapies

Nov. 20, 1997

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Nov. 20, 1997

Idec begins phase I/II trial for 9-AC

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...